share_log

通化东宝:德谷胰岛素利拉鲁肽注射液申报临床获得批准

JRJ Finance ·  Apr 29 03:39

通化东宝公告,德谷胰岛素利拉鲁肽注射液申报临床获得批准。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment